Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
BWX Technologies, Inc. (BWXT) is a U.S.-based nuclear technology and manufacturing company that operates primarily in the nuclear energy, defense, and medical radioisotope industries. The company is best known as the sole manufacturer of nuclear reactors and nuclear fuel for the U.S. Naval Nuclear Propulsion Program, supporting nuclear-powered submarines and aircraft carriers. BWXT also provides nuclear components, services, and advanced technologies for government and commercial customers.
The company’s primary revenue drivers include long-term government contracts for naval nuclear propulsion, nuclear operations and environmental site management, and the production of medical radioisotopes used in cancer diagnostics and therapeutics. BWXT holds a unique strategic position due to its specialized nuclear manufacturing capabilities, regulatory expertise, and long-standing relationships with U.S. government agencies. The company traces its roots to Babcock & Wilcox, founded in 1867, and became an independent, publicly traded entity in 2015 following a corporate separation, subsequently rebranding as BWX Technologies, Inc.
Business Operations
BWXT operates through two primary business segments: Government Operations and Commercial Operations. The Government Operations segment generates the majority of revenue and includes the design, manufacturing, and fuel loading of naval nuclear reactors, as well as management of nuclear facilities for the U.S. Department of Energy and other federal agencies. This segment also encompasses classified nuclear services and advanced reactor development for national security applications.
The Commercial Operations segment focuses on nuclear components, fuel handling systems, and specialty manufacturing, as well as medical radioisotopes through its subsidiary BWXT Medical Ltd. BWXT controls specialized nuclear manufacturing facilities, licensed nuclear sites, and proprietary reactor and fuel technologies. The company operates through multiple wholly owned subsidiaries and participates in joint ventures related to environmental cleanup and nuclear site management for the U.S. government.
Strategic Position & Investments
BWXT’s strategic direction centers on expanding its role in advanced nuclear technologies, national security applications, and medical isotopes. Growth initiatives include investment in small modular reactors (SMRs), microreactors for defense and remote energy applications, and expanded production of radioisotopes such as Actinium-225 for targeted cancer therapies. These initiatives align with U.S. government priorities for clean energy, energy security, and advanced defense systems.
The company has pursued targeted acquisitions and internal investments to strengthen its nuclear services and medical technology platforms. Notable subsidiaries include BWXT Nuclear Operations Group, BWXT Technical Services Group, and BWXT Medical Ltd., each supporting different aspects of the company’s portfolio. BWXT continues to allocate capital toward modernizing nuclear manufacturing infrastructure and advancing next-generation reactor technologies.
Geographic Footprint
BWXT is headquartered in North America, with its corporate headquarters located in Lynchburg, Virginia. The company maintains major operational facilities across the United States, including manufacturing and nuclear operations sites in Virginia, Ohio, Indiana, and Tennessee. These facilities support both defense-related and commercial nuclear activities.
Internationally, BWXT has a significant presence in Canada, primarily through BWXT Canada Ltd., which supports nuclear services and components for Canadian nuclear power programs. The company also serves customers in Europe and other global markets through exports, partnerships, and specialized nuclear services, giving it an international operational and investment footprint despite its predominantly U.S.-focused revenue base.
Leadership & Governance
BWXT is led by an executive team with deep experience in nuclear engineering, government contracting, and advanced manufacturing. The leadership emphasizes operational excellence, nuclear safety, regulatory compliance, and long-term partnerships with government and commercial customers. The company operates under a governance framework aligned with U.S. public company standards and defense-sector compliance requirements.
Key executives include:
- Rex D. Geveden – President and Chief Executive Officer
- Robert L. Duffy – Senior Vice President and Chief Administrative Officer
- Kristen J. Stephens – Senior Vice President and Chief Financial Officer
- Joseph K. Miller – President, Government Operations
- Gary D. Camper – President, Commercial Operations
The leadership team’s strategic vision focuses on leveraging BWXT’s nuclear expertise to support national security, advance clean energy solutions, and expand the company’s role in life-saving medical technologies.